Electrical Stimulation With Interferential Current in the Non-especific Chronic Low Back Pain: Effects on the Autonomic Nervous System.
NCT ID: NCT04483128
Last Updated: 2021-07-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
56 participants
INTERVENTIONAL
2020-06-01
2020-12-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Most of physiotherapy approaches focus only in biomechanical aspects, leaving aside what kind of factors could perpetuate CLBP. Since 1985, ANSb was studied due to its potential contribution to chronic pain.
Electrical stimulation, through interferential currents (IFC), it's a safe and well-known therapy used in CLBP with good outcomes regarding pain relief.
The main objective of this study it's to quantify the association between CLBP and ANSb alterations. In second place, the research team aims to record the influence of IFC over pain and ANSb in those subjects.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Interferential Current in Lower Back
NCT03483064
Use of Biofeedback Training to Correct Abnormal Neuromechanical Pattern in Chronic Low Back Pain Patients
NCT02239289
Ultrasound-guided Neuromodulation Percutaneous in Lower Back Pain
NCT04347265
Frequency Parameter Used to Apply Ultrasound-guided Neuromodulation Percutaneous
NCT05106920
Interferential Current Treatment Reduces Low Back Pain and Improves Functionality in Patients With Chronic Low Back Pain.
NCT05843136
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Secondly, patients will be provided of an informed consent specific for the present study, according to the legal forms. Participants must agree with all the information and sign the document.
At this point, patients will be interviewed individually by a researcher to collect all the data regarding to the Clinical History in Physiotherapy.
In the next step, patients will be randomized into two different groups by choosing one opaque envelope, containing a number for the allocation. A researcher will make the final allocation depending on the number. Patients were unaware of the group allocation for masking.
This study has to possible groups with a common indication for both:
1. Experimental group: Patients allocated in this group will receive one single session of interferential current (IFC). Current used a carrier frequency of 4.000 Hz, 65Hz of amplitude modulated frequency (AMF) with sweep frecuency of 95Hz in a 1:1 swing pattern (quadripolar technique). Intensity was adjusted according to patient's tolerance without visible muscle twitches. The session will last 25 min.
2. Control group: This group will receive the same intervention than experimental one but with no intensity, for 25 minutes. Patients will keep his general practitioner's indications about pharmacology.
3. Common indication: Both groups will get instructions to perform a set of home-based exercises for core strengthening after variable collecting.
Before and after the session, all the variable measurements will be collected in the same environmental conditions by the same researcher. Basal measurement (before intervention) will be recorded 15 minutes before session for 10 minutes. The second measurement will be taken while the patient recieves the intervention for 20 minutes.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
* Experimental group: Participants in this group will receive electrical stimulation with interferential current. They will get also instructions to perform core strengthening exercises at home, after variable collection.
* Control group: Participants in this group will recieve the same electrical stimulation than in the experimental group but with no intensity. This group will get too instructions to perform core strengthening exercises at home (after variable collection) and follow General Practitioner indications about pharmacology.
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sham IFC therapy: Control group
This group will recieve also instructions for core strengthening exercises and a single session of interferential current (IFC).
IFC parameters:
1. Carrier frequency of 4000 Hz
2. Amplitude modulated frequency of 65 Hz (AMF)
3. Sweep frequency of 95 Hz of modulation with a 1:1 swing pattern, in a quadripolar technique.
4. NO intensity (0 mA)
5. Session duration: 25 minutes
Electrical stimulation: Interferential Current (IFC): Control Group
Application of IFC with Sonopuls 692® (Enraf-Nonius BV, Rotterdam, The Netherlands) device. Parameters:
1. Carrier frequency of 4000 Hz
2. Amplitude modulated frequency of 65 Hz (AMF)
3. Sweep frequency of 95 Hz of modulation with a 1:1 swing pattern, in a quadripolar technique.
4. NO intensity (0 mA)
5. Session duration: 25 minutes
IFC therapy: Experimental group
This group will recieve also instructions for core strengthening exercises and a single session of interferential current (IFC).
IFC parameters:
1. Carrier frequency of 4000 Hz
2. Amplitude modulated frequency of 65 Hz (AMF)
3. Sweep frequency of 95 Hz of modulation with a 1:1 swing pattern, in a quadripolar technique.
4. Intensity will depend on subjet's tolerance but without generating visible muscle twitches.
5. Session duration: 25 minutes
Electrical stimulation: Interferential Current (IFC): Experimental Group
Application of IFC with Sonopuls 692® (Enraf-Nonius BV, Rotterdam, The Netherlands) device. Parameters:
1. Carrier frequency of 4000 Hz
2. Amplitude modulated frequency of 65 Hz (AMF)
3. Sweep frequency of 95 Hz of modulation with a 1:1 swing pattern, in a quadripolar technique.
4. Intensity will depend on subjet's tolerance but without generate visible muscle twitches.
5. Session duration: 25 minutes
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Electrical stimulation: Interferential Current (IFC): Experimental Group
Application of IFC with Sonopuls 692® (Enraf-Nonius BV, Rotterdam, The Netherlands) device. Parameters:
1. Carrier frequency of 4000 Hz
2. Amplitude modulated frequency of 65 Hz (AMF)
3. Sweep frequency of 95 Hz of modulation with a 1:1 swing pattern, in a quadripolar technique.
4. Intensity will depend on subjet's tolerance but without generate visible muscle twitches.
5. Session duration: 25 minutes
Electrical stimulation: Interferential Current (IFC): Control Group
Application of IFC with Sonopuls 692® (Enraf-Nonius BV, Rotterdam, The Netherlands) device. Parameters:
1. Carrier frequency of 4000 Hz
2. Amplitude modulated frequency of 65 Hz (AMF)
3. Sweep frequency of 95 Hz of modulation with a 1:1 swing pattern, in a quadripolar technique.
4. NO intensity (0 mA)
5. Session duration: 25 minutes
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects with a minimal pain of 3/10 according to NPRS
* Subjects with informed consent read and signed.
* Subjects not undergoing any other physical therapy intervention.
Exclusion Criteria
* Personal Psychological Apprehension Scale (PPAS) score higher than 37.5.
* Contraindication for electrical stimulation.
* Any regular use of medications known to affect the function of the autonomic nervous system (ANS) or pain perception, including antidepressant, benzodiazepines, anti-inflammatory drugs and beta-blockers, 2 weeks before participating in this study.
* Ineligibility to participate determined by the researches.
* Neurological, musculoskeletal or sensory affectations.
* Evidence of infectious process, fever or hypotension.
* Metallic implants in low back area or treated area
* No surgical interventions in low back area
* Not being under pharmacological treatment with influence in Autonomic Nervous System like antidepressants.
18 Years
65 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Seville
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Manuel Albornoz Cabello
Doctor in Physiotherapy (PhD)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Manuel Albornoz Cabello
Seville, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CIFSNA2020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.